Go to KM Summary
ID Title Status Sort descending Last Updated KM Node Tags
3072 Overview of NHM PIP Depreciated 21/01/2024
4850 Private health care led partnership Depreciated 27/04/2024
1253 Line Probe Assay [LPA] in DR-TB Diagnosis Depreciated 03/05/2022
4851 Corporate Sector Engagement Depreciated 13/03/2024
1363 Storage of Slides for QA Depreciated 31/05/2022
859 Importance of Private Sector Engagement Depreciated 10/10/2022
98 Natural History of TB Depreciated 05/02/2023
3322 Determining the Beneficiary status Depreciated 03/10/2023 DBT, Finance related matters
2283 Quality control management Depreciated 20/04/2024
5741 Why is System for TB Elimination in Private Sector (STEPS) Unique? Depreciated 20/04/2024
257 Direct benefit Transfer [DBT] under NTEP Depreciated 27/04/2024 DBT
4847 Incentives Depreciated 27/04/2024
512 Drug Sensitive Tuberculosis [DS-TB] Depreciated 15/04/2024
112 Naming Tuberculosis Depreciated 03/05/2022
37 Structures for ACSM under NTEP Depreciated 23/01/2024
819 Support for Rehabilitation Depreciated 13/05/2024
2251 99 DOTS and MERM boxes Depreciated 26/07/2023 Digital interventions
845 Nikshay Aushadhi Depreciated 14/04/2024
141 Roles of IRLs Depreciated 14/07/2022
161 Characteristics of good quality sputum sample Depreciated 09/05/2024
3701 Enabling DSC in PFMS by adding and approving opening balance Depreciated 11/11/2022
5716 Private Practitioners Depreciated 21/04/2024
3908 Mechanism of action-anti TB drugs first line and second line Depreciated 11/01/2024
2420 Store Visits in NTEP Live 16/06/2022
2418 How to do monitoring of sub stores Live 16/06/2022
2605 Microscope Live 09/01/2024
2592 Corporate Sector Engagement Live 21/01/2024 Corporate sector engagement & TB
2593 TB Free Workplace Live 13/03/2024
2594 Corporate Social Responsiblity [CSR] in TB Live 31/07/2023 Corporate sector engagement & TB, Bilateral cooperation and Donor coordination
2613 Patient-wise Boxes [PWB] Live 10/04/2023